The strongest risk effect from ApoE ε4 for AD is in East-Asian populations, with the lowest risk from ApoE ε4 in African (AF)-Ancestry populations (such as Ibadan individuals from Nigeria and African Americans (AA)) [3,6–10]. This evidence concerns the gene APOE and Alzheimer disease.